Fetal Hydantoin Syndrome: A Case Report
- PMID: 38161950
- PMCID: PMC10756398
- DOI: 10.7759/cureus.49663
Fetal Hydantoin Syndrome: A Case Report
Abstract
Epilepsy is not a common cause of morbidity in pregnancy. It has widespread effects on maternal and fetal health necessitating adequate control of seizures. Many anti-seizure medications (ASM) have teratogenic effects on the fetus. We report a case of severe fetal hydantoin syndrome resulting in life-threatening major congenital anomalies. The mother was on phenytoin for the last three years and the pregnancy was not registered. We discuss various features of fetal hydantoin syndrome and the ideal management of epilepsy in pregnancy in brief.
Keywords: antiepileptic drugs; fetal embryopathy; fetal hydantoin syndrome; phenytoin embryopathy; women with epilepsy.
Copyright © 2023, Aggarwal et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures

References
-
- Community-based, prospective, controlled study of obstetric and neonatal outcome of 179 pregnancies in women with epilepsy. Viinikainen K, Heinonen S, Eriksson K, Kälviäinen R. Epilepsia. 2006;47:186–192. - PubMed
-
- Management of women with epilepsy: from preconception to post-partum. Laganà AS, Triolo O, D'Amico V, et al. Arch Gynecol Obstet. 2016;293:493–503. - PubMed
-
- Epilepsy in pregnancy and reproductive outcomes: a systematic review and meta-analysis. Viale L, Allotey J, Cheong-See F, et al. Lancet Lond Engl. 2015;7:1845–1852. - PubMed
-
- Antiepileptic drugs (AEDs) during pregnancy and risk of congenital jaw and oral malformation. Koo J, Zavras A. Oral Dis. 2013;19:712–720. - PubMed
Publication types
LinkOut - more resources
Full Text Sources